Shares of Merit Medical Systems MMSI were flat in after-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share increased 35.00% year over year to $0.54, which beat the estimate of $0.43.
Revenue of $258,004,000 up by 0.03% year over year, which beat the estimate of $250,450,000.
Outlook
The upcoming fiscal year's EPS expected to be between $1.84 and $1.98.
The upcoming fiscal year's revenue expected to be between $990,000,000 and $1,010,000,000.
Conference Call Details
Date: Feb 24, 2021
Time: 05:00 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/cxg5cavx
Technicals
Company's 52-week high was at $61.23
52-week low: $25.18
Price action over last quarter: Up 9.44%
Company Profile
Merit Medical Systems, Inc. is a South Jordan, Utah, based medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm currently reports through two overarching units, Cardiovascular (96% of 2018 revenue) and Endoscopy (4%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for approximately 55% of 2018 revenue and international sales making up the remaining 45%.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
